Healthcare Industry News:  lopinavir/ritonavir 

Biopharmaceuticals Regulatory HIV/AIDS

 News Release - February 16, 2007

Anti-HIV Medication PREZISTA(TM) Receives Conditional Marketing Authorisation in the European Union



Source: Tibotec Pharmaceuticals

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.